Olema Pharmaceuticals (OLMA) PT Raised to $58 at JPMorgan
Tweet
Share
E-mailGet Alerts OLMA Hot Sheet
Price: $11.45 +8.74%
Rating Summary:
14 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 32
Rating Summary:
14 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 32
Join SI Premium – FREE
JPMorgan analyst Anupam Rama raised the price target on Olema Pharmaceuticals (NASDAQ: OLMA) to $58.00 (from $55.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Morgan Stanley Upgrades Telecom Argentina (TEO) to Overweight
- Australia & New Zealand Banking Group (ANZ:AU) (ANZBY) PT Lowered to AUD35.80 at UBS
- Sugi Holdings Co Ltd (7649:JP) (SGIPF) PT Lowered to JPY3,800 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
